KMR Group’s Trial Cost Program offers a comprehensive analysis of trial cost performance through findings of the Trial Cost Study and assessment of study data via the online Trial Cost Metrix tool.
The Trial Cost Study is critical to evaluating cost profile and to better understanding at a macro level the trial design and operational factors that drive cost. Advanced statistics are used to identify key cost drivers such as the cost to add an additional country or patient.
Trial Cost Metrix is a user-friendly web-based application that enables myriad combinations of cost types and cost factors to be evaluated in a variety of formats and break-outs, including therapy area, disease, phase, patient type, molecule size and normalized by factors such as patients, sites and visits.
Please fill out the form below if you would like us to contact you with more information.
